The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery
Author:
Affiliation:
1. Cleveland Clinic, Cleveland, Ohio
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference17 articles.
1. The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ;Bex;Eur Urol,2002
2. Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place;Wagner;J Urol,1999
3. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma;Thomas;J Urol,2009
4. Sunitinib for treatment of advanced renal cell cancer: primary tumor response;van der Veldt;Clin Cancer Res,2008
5. Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients;Seidel;World J Urol,2011
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting;Journal of Urologic Oncology;2024-07-31
2. Effects of neoadjuvant VEGF‑TKI treatment on surgery for renal cell carcinoma: A systematic review and meta‑analysis;Oncology Letters;2024-02-19
3. Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma;JAMA Oncology;2023-12-14
4. Genitourinary cancer neoadjuvant therapies: current and future approaches;Trends in Cancer;2023-12
5. Neoadjuvant nivolumab and cabozantinib in advanced renal cell carcinoma in a horseshoe kidney – how to achieve a safe and radical resection? a case report and review of the literature;Frontiers in Oncology;2023-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3